Measures of striatal insulin resistance in a 6-hydroxydopamine model of Parkinson's disease
- 13 November 2008
- journal article
- Published by Elsevier BV in Brain Research
- Vol. 1240, 185-195
- https://doi.org/10.1016/j.brainres.2008.08.089
Abstract
No abstract availableKeywords
This publication has 69 references indexed in Scilit:
- Activation of c-Jun N-Terminal Protein Kinase Is a Common Mechanism Underlying Paraquat- and Rotenone-Induced Dopaminergic Cell ApoptosisToxicological Sciences, 2007
- Immune reactivity towards insulin, its amyloid and protein S100B in blood sera of Parkinson's disease patientsEuropean Journal of Neurology, 2007
- CGP 56999A, a GABAB receptor antagonist, enhances expression of brain-derived neurotrophic factor and attenuates dopamine depletion in the rat corpus striatum following a 6-hydroxydopamine lesion of the nigrostriatal pathwayNeuroscience Letters, 2006
- Neuronal insulin signal transduction mechanisms in diabetes phenotypesNeurobiology of Aging, 2005
- Akt Is Essential for Insulin Modulation of Amphetamine-Induced Human Dopamine Transporter Cell-Surface RedistributionMolecular Pharmacology, 2005
- Neural connections between the hypothalamus and the liverThe Anatomical Record Part A: Discoveries in Molecular, Cellular, and Evolutionary Biology, 2004
- Classic toxin-induced animal models of Parkinson?s disease: 6-OHDA and MPTPCell and tissue research, 2004
- SOCS-1 and SOCS-3 Block Insulin Signaling by Ubiquitin-mediated Degradation of IRS1 and IRS2Journal of Biological Chemistry, 2002
- Effects of unilateral striatal dopamine depletion on tongue force and rhythm during licking in rats.Behavioral Neuroscience, 1999
- Glucose intolerance in parkinson's diseaseJournal of Chronic Diseases, 1974